Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial Article

sustainable development goals

publication date

  • June 1, 2020

webpage

published in

keywords

  • clinical trial
  • neurokinin 1 receptor (NK1R)
  • pruritus
  • psoriasis
  • serlopitant
  • substance P.

start page

  • 1314

end page

  • 1320

volume

  • 82

issue

  • 6